{"SPADE_UN_26611": {"Sequence Information": {"Peptide Name": "EB1", "Sequence": "XKLLKLLKLLX", "Sequence Length": 11, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Antimicrobial Peptide-Peptoid Hybrids with and without Membrane Disruption.", "Pubmed ID": "38062792", "Reference": "ACS Infect Dis. 2023;9:2593-2606", "Author": "Bonvin E, Personne H, Paschoud T, Reusser J, Gan BH, Luscher A, Köhler T, van Delden C, Reymond JL", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/38062792"}], "SPADE ID": "SPADE_UN_26611", "Similar Sequences": [{"SPADE_ID": "SPADE_N_06023", "Similarity": 1.0, "Sequence": "KLLKKLLKLL"}, {"SPADE_ID": "SPADE_N_06282", "Similarity": 1.0, "Sequence": "LKLLKKLLKKLLKLL"}, {"SPADE_ID": "SPADE_N_07259", "Similarity": 1.0, "Sequence": "RKKRRQRRRGGGKLLKLLLKLLLKLLK"}], "Hemolytic Activity": "Human erythrocytes:5% Hemolysis=1000 µg/ml,Human embryonic kidney HEK293 cells:IC50=110±6 µM", "Target Organism": "Escherichia coli W3110(MIC=2µg/ml),Escherichia coli W3110(MIC=32µg/ml),Escherichia coli W3110(MIC=1µg/ml),Pseudomonas aeruginosa PAO1(MIC=4µg/ml),Pseudomonas aeruginosa PAO1(MIC=16µg/ml),Pseudomonas aeruginosa PAO1(MIC=2µg/ml),Acinetobacter baumannii ATCC 19606(MIC=2µg/ml),Acinetobacter baumannii ATCC 19606(MIC=>32µg/ml),Acinetobacter baumannii ATCC 19606(MIC=1-2µg/ml),Klebsiella pneumoniae NCTC 418(MIC=8µg/ml),Klebsiella pneumoniae NCTC 418(MIC=>32µg/ml),Klebsiella pneumoniae NCTC 418(MIC=1-2µg/ml),Staphylococcus aureus COL(MIC=8µg/ml),Staphylococcus aureus COL(MIC=32µg/ml),Staphylococcus aureus COL(MIC=2µg/ml),Pseudomonas aeruginosa PA14(MIC=4µg/ml),Pseudomonas aeruginosa PA14 4.18(MIC=32µg/ml),Pseudomonas aeruginosa ZEM1.A(MIC=2-4µg/ml),Pseudomonas aeruginosa ZEM9.A(MIC=16µg/ml),Enterobacter cloacae(MIC=8µg/ml),Klebsiella pneumoniae Oxa-48(MIC=8-16µg/ml),Stenotrophomonas maltophilia(MIC=2-4µg/ml),Burkholderia cenocepacia(MIC=>32µg/ml),Staphylococcus aureus Newman(MIC=32µg/ml),Staphylococcus aureus Newman(MIC=2µg/ml),Pseudomonas aeruginosa PA14(MIC=2µg/ml),Pseudomonas aeruginosa PA14 4.18(MIC=2µg/ml),Human lung carcinoma A549(IC50=69±2µM)"}}}